🩺

Trial by Wire

About this publication

Trial by Wire is a weekly newsletter that interprets the most important clinical trials, late-breaking studies, and evolving evidence in interventional cardiology.

Written from a clinician’s perspective, it distills complex data into concise, practice-relevant insights — connecting the rigor of research with the realities of patient care.


Why subscribe

Because in our field, decisions are measured in millimeters and evidence matters.

Each issue of Trial by Wire focuses on clarity, context, and clinical relevance — not headlines.

Subscribers receive:

  • Summaries of landmark and contemporary interventional trials

  • Critical appraisals of methodology and endpoints

  • Practice implications for the cath lab, conference discussions, and bedside decision-making

No noise. No oversimplified takes. Just data interpreted by a peer who shares your vantage point.


Who it’s for

Practicing interventional cardiologists, fellows-in-training, and cardiovascular researchers who want to stay aligned with the pulse of current evidence — without losing depth or nuance.


About the author

Dr Shailesh Singh,

MBBS, MD (Internal Medicine), DNB (Internal Medicine), DrNB (Cardiology)

Interventional Cardiologist.

Dr Singh writes Trial by Wire to bridge the gap between rapidly emerging trial data and practical, evidence-based intervention.

User's avatar

Subscribe to Trial By Wire

Weekly evidence-based insights from landmark and emerging interventional cardiology trials.

People